Your browser doesn't support javascript.
loading
Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
Ng, Yixiang; Nandar, Khine; Chua, Lily Ai Vee; Mak, Tze Minn; Foo, Kelly; Muhammad, Imran Roshan; Low, Constance Khia Ki; Ma, Stefan; Ooi, Steven Peng-Lim; Lin, Raymond Tzer Pin; James, Lyn; Lee, Vernon Jian Ming.
Afiliación
  • Ng Y; Epidemiology and Disease Control Division, Ministry of Health, Singapore. Electronic address: NG_yixiang@moh.gov.sg.
  • Nandar K; Communicable Disease Division, Ministry of Health, Singapore.
  • Chua LAV; Epidemiology and Disease Control Division, Ministry of Health, Singapore.
  • Mak TM; National Public Health Laboratory, Ministry of Health, Singapore.
  • Foo K; Communicable Disease Division, Ministry of Health, Singapore.
  • Muhammad IR; Communicable Disease Division, Ministry of Health, Singapore.
  • Low CKK; Communicable Disease Division, Ministry of Health, Singapore.
  • Ma S; Epidemiology and Disease Control Division, Ministry of Health, Singapore.
  • Ooi SP; Communicable Disease Division, Ministry of Health, Singapore.
  • Lin RTP; National Public Health Laboratory, Ministry of Health, Singapore.
  • James L; Epidemiology and Disease Control Division, Ministry of Health, Singapore.
  • Lee VJM; Communicable Disease Division, Ministry of Health, Singapore.
Vaccine ; 37(29): 3925-3931, 2019 06 27.
Article en En | MEDLINE | ID: mdl-31160102
Influenza outbreaks occur periodically in Long Term Care Facilities (LTCFs) and vaccination is critical in preventing influenza infections. We evaluated the influenza vaccine effectiveness (VE) during respiratory outbreaks in LTCFs reported to the Ministry of Health, Singapore in 2017. A test-negative design was used to estimate the ratio of the odds of testing positive for influenza among vaccinated individuals to the odds among unvaccinated individuals. The VE was calculated as (1-odds ratio) × 100%. For adjusted VE, the estimates were derived using logistic regression adjusted for age group, gender, month of illness, and number of days from date of illness onset till to swab collection date. Estimates by influenza subtypes and post-vaccination time periods (15-180 days & 181-365 days) were also calculated using stratified data. 264 individuals, with 118 laboratory-confirmed influenza cases [32 A(H1N1)pdm09, 75 A(H3N2), 11 A(untypable)], were included in the analysis. No one was identified to be infected with influenza B. The overall adjusted VE estimate was 40.5% (95% CI: -12.2-68.5%), while the subtype-specific adjusted VE estimates were -43.4% (95% CI: -312.4-50.2%) against A(H1N1)pdm09 and 57.1% (95% CI: 5.7-80.5%) against A(H3N2). At 15-180 days post-vaccination period, the adjusted VEs were 59.3% (95% CI: 18.0-79.8%) against all influenza, 35.4% (95% CI: -123.5-81.3%) against A(H1N1)pdm09 and 67.9% (95% CI: 22.5-86.7%) against A(H3N2). Estimates were not significant at 181-365 days post-vaccination. The influenza vaccine showed varying effectiveness among individuals in Singapore's LTCFs in 2017, with a higher effectiveness among those who were more recently vaccinated. It remains an important tool in preventing influenza infections, especially for those who are at high risk of influenza-related complications.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Brotes de Enfermedades / Vacunación / Cuidados a Largo Plazo / Gripe Humana / Potencia de la Vacuna Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Brotes de Enfermedades / Vacunación / Cuidados a Largo Plazo / Gripe Humana / Potencia de la Vacuna Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos